Hence, there is the exciting possibility of targeting Kv3 channel function as a new locus for novel treatment, whilst also advancing our understanding of the mechanisms by which such deficits give rise to E-I imbalance that underpin a variety of neurodevelopmental, neurological, and psychiatric disorders. This evidence concerns the gene SERPINB1 and psychiatric disorder.